Markets › News › DeFi

Injective Partners with BDACS for Won-Backed Tokenized Asset Settlement

Injective and BDACS will use the KRW1 stablecoin for settling tokenized assets on Injective's platform.

Injective and BDACS will use the KRW1 stablecoin for settling tokenized assets on Injective's platform. Injective (INJ) is trading at $8.98, up 1.6% since this brief published. This is an original TLT brief based on reporting by Cryptopolitan, with live market data added, as of Tue, 20 Oct 2026 23:00:05 UTC.

Why it matters

This partnership provides Korean institutions with a local currency option for trading tokenized assets, potentially increasing adoption and reducing reliance on dollar-denominated stablecoins.

Key takeaways
  • Injective and BDACS partner to use KRW1 stablecoin for tokenized asset settlement.
  • Move gives Korean institutions a local currency option for trading tokenized assets.
  • INJ token price up 3.82% in 24 hours following the announcement.
The story so far · 2 briefs
  1. Injective Partners with BDACS for Korean Won Stablecoin Integration
  2. Injective Partners with BDACS for Won-Backed Tokenized Asset Settlement — this brief

Injective, a blockchain platform for decentralized finance applications, has announced a partnership with South Korean custody firm BDACS to use the won-backed stablecoin KRW1 for settling tokenized assets on its network.

The agreement, announced on October 20, 2026, makes KRW1 the exclusive settlement asset for tokenized real-world assets on Injective's platform. This move is designed to cater to Korean institutions, providing them with a local currency option for trading tokenized assets.

Cryptopolitan is the only outlet reporting on this development, so the details cannot be corroborated with other sources. However, the partnership highlights the growing trend of using local currency stablecoins for blockchain-based asset trading.

The announcement comes at a time when the total crypto market cap is around $2.84 trillion, with the overall market showing a broad uptrend. Bitcoin has gained 1.08% in the past 24 hours, while the Fear & Greed index stands at 55, indicating a state of 'Greed' in the market.

Injective's native token, INJ, has seen a 3.82% increase in price over the past 24 hours, reaching $8.84, and is up 8.21% over the past week. The market cap of INJ is currently $883.72 million.

Market reaction since this brief Live

Since this brief published about 1 hour ago, Injective (INJ) has moved from $8.84 to $8.98 — +1.58%.

$8.82$8.87$8.91$8.95$9.00 published · $8.84 now · $8.98 (+1.58%) Oct 20 21:33 UTC Oct 20 23:00 UTC
BeforeSince publishPublished · $8.84

The chart plots INJ's price: grey is the move before this brief published, the vertical dashed line marks the moment it published, the horizontal dashed line is the price then, and the coloured area is the move since — from TLT's market data (daily resolution). It shows what happened after the news, not that the news caused it; many factors move prices. Not financial advice.

What this means in naira

At today's peer-to-peer rate, 1 INJ ≈ ₦12,245.85 (about $8.98), up 4.3% over 24 hours. The naira itself trades about 2.3% above the official rate on the P2P market, so a Nigerian buyer's effective cost differs from the headline dollar price.

Live market data

Current prices for the asset in this story — live, source-stamped, updated every 15 minutes.

#81
$8.98 ▲ 4.25%
+1.58% since this brief published
7d +8.21%MCap $898.56MFull INJ data →
The market when this published · October 20, 2026
Total market cap$2.84T
Bitcoin 24h+1.08%
Ethereum 24h+2.19%
BTC dominance58.6%
Fear & Greed55 · Greed
On-chain & primary-source check

Figures and sectors in this story, checked live against on-chain aggregators · October 20, 2026.

SectorTokenized real-world assets (RWA)$3.91Bacross 27 protocolsDeFiLlama ↗

TLT reads these figures directly from on-chain aggregators (DeFiLlama, mempool.space) at build time — independent of what any outlet reported. Sector totals aggregate every protocol DeFiLlama tracks in that category. Values are live and will change.

Injective Partners with BDACS for Won-Backed Tokenized Asset — questions & answers

What is the KRW1 stablecoin?

KRW1 is a stablecoin backed by the South Korean won, designed to facilitate transactions in the local currency.

Why is this partnership significant?

It provides Korean institutions with a local currency option for trading tokenized assets, potentially increasing adoption and reducing reliance on dollar-denominated stablecoins.

How will this affect the INJ token?

The partnership has already led to a 3.82% increase in the price of INJ over the past 24 hours.

How much is 1 Injective worth in naira today?

About ₦12,245.85 at the live peer-to-peer (P2P) USDT rate, which is what Nigerians typically trade at — equivalent to roughly $8.98. The naira price moves with both INJ's US-dollar price and the USDT/NGN rate; use our Injective in naira page for any amount.

Has Injective's price moved since this brief was published?

INJ is up 1.58% since this brief first published — trading at $8.98 now versus $8.84 at publication. TLT re-checks this figure against CoinGecko and Binance every 15 minutes.

Which outlets reported this story?

This is an original TLT brief that synthesises reporting from Cryptopolitan. It is not a copy of any one article — follow the source links above for the original reporting.

TLT Newsdesk Data-stamped

TLT's newsdesk writes original briefs by synthesising coverage from across the crypto press — 50+ outlets including CoinDesk, The Block, Decrypt and Cointelegraph — cross-checking the figures they report — and verifying them against on-chain data from DeFiLlama and mempool.space — plus live market context (CoinGecko, Binance). We summarise and link to every source; we never reproduce full articles. Read our editorial standards and how we use AI. Not financial advice.

Market data verified against CoinGecko & Binance · October 20, 2026 ⛓ Timestamped at Bitcoin block #972,384 sha256:95b33fe1deb7d1c1
Based on reporting by Cryptopolitan — this is an original TLT summary with live market data, not the original article.Cryptopolitan · Oct 20 21:33 ↗

Original summary — not financial advice. This is an original TLT brief that summarises a development reported elsewhere and adds live market data for context; it is not the original article and reproduces no part of it. Follow the source link above for full details. Crypto is volatile and high-risk — always do your own research.